These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 20476927)

  • 21. Anti-lipoprotein lipase antibodies: a new player in the complex atherosclerotic process in systemic lupus erythematosus?
    de Carvalho JF; Borba EF; Viana VS; Bueno C; Leon EP; Bonfá E
    Arthritis Rheum; 2004 Nov; 50(11):3610-5. PubMed ID: 15529371
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of hormone therapy on C-reactive protein and IL-6 in postmenopausal women: a review article.
    Lakoski SG; Herrington DM
    Climacteric; 2005 Dec; 8(4):317-26. PubMed ID: 16390766
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Infections and autoimmune diseases.
    Bach JF
    J Autoimmun; 2005; 25 Suppl():74-80. PubMed ID: 16278064
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reversal of ongoing proteinuria in autoimmune mice by treatment with C-reactive protein.
    Rodriguez W; Mold C; Kataranovski M; Hutt J; Marnell LL; Du Clos TW
    Arthritis Rheum; 2005 Feb; 52(2):642-50. PubMed ID: 15692982
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fluvastatin inhibits the expression of tumor necrosis factor-alpha and activation of nuclear factor-kappaB in human endothelial cells stimulated by C-reactive protein.
    Wang HR; Li JJ; Huang CX; Jiang H
    Clin Chim Acta; 2005 Mar; 353(1-2):53-60. PubMed ID: 15698590
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Complement and its role in innate and adaptive immune responses.
    Dunkelberger JR; Song WC
    Cell Res; 2010 Jan; 20(1):34-50. PubMed ID: 20010915
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interferon-alpha mediates suppression of C-reactive protein: explanation for muted C-reactive protein response in lupus flares?
    Enocsson H; Sjöwall C; Skogh T; Eloranta ML; Rönnblom L; Wetterö J
    Arthritis Rheum; 2009 Dec; 60(12):3755-60. PubMed ID: 19950271
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mammalian N-glycan branching protects against innate immune self-recognition and inflammation in autoimmune disease pathogenesis.
    Green RS; Stone EL; Tenno M; Lehtonen E; Farquhar MG; Marth JD
    Immunity; 2007 Aug; 27(2):308-20. PubMed ID: 17681821
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [C-reactive protein: cardiovascular issues of an acute-phase protein].
    Amezcua-Guerra LM; Springall del Villar R; Bojalil Parra R
    Arch Cardiol Mex; 2007; 77(1):58-66. PubMed ID: 17500194
    [TBL] [Abstract][Full Text] [Related]  

  • 30. C-reactive protein, atherosclerosis and cardiovascular disease. An update.
    Camici M
    Minerva Cardioangiol; 2002 Aug; 50(4):327-31. PubMed ID: 12147963
    [TBL] [Abstract][Full Text] [Related]  

  • 31. C-reactive protein induces high-mobility group box-1 protein release through activation of p38MAPK in macrophage RAW264.7 cells.
    Kawahara K; Biswas KK; Unoshima M; Ito T; Kikuchi K; Morimoto Y; Iwata M; Tancharoen S; Oyama Y; Takenouchi K; Nawa Y; Arimura N; Jie MX; Shrestha B; Miura N; Shimizu T; Mera K; Arimura S; Taniguchi N; Iwasaka H; Takao S; Hashiguchi T; Maruyama I
    Cardiovasc Pathol; 2008; 17(3):129-38. PubMed ID: 18402807
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of the innate immune response in autoimmune disease.
    Lang KS; Burow A; Kurrer M; Lang PA; Recher M
    J Autoimmun; 2007 Dec; 29(4):206-12. PubMed ID: 17904335
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [C-reactive protein in the pathogenesis of atherosclerosis: advantage and pitfalls of the "Mainz hypothesis"].
    Kunes P
    Cas Lek Cesk; 2005; 144(1):25-31. PubMed ID: 15789778
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells.
    Kang DH; Park SK; Lee IK; Johnson RJ
    J Am Soc Nephrol; 2005 Dec; 16(12):3553-62. PubMed ID: 16251237
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Inflammatory markers and cytokines in cardiovascular disease].
    Ogiwara F; Takahashi M; Ikeda U
    Rinsho Byori; 2004 Aug; 52(8):686-92. PubMed ID: 15478624
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Rheumatoid arthritis, inflammation, and atherosclerosis].
    Hürlimann D; Enseleit F; Ruschitzka F
    Herz; 2004 Dec; 29(8):760-8. PubMed ID: 15599672
    [TBL] [Abstract][Full Text] [Related]  

  • 37. C-reactive protein: an activator of innate immunity and a modulator of adaptive immunity.
    Du Clos TW; Mold C
    Immunol Res; 2004; 30(3):261-77. PubMed ID: 15531769
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Complex Role of C-Reactive Protein in Systemic Lupus Erythematosus.
    Enocsson H; Karlsson J; Li HY; Wu Y; Kushner I; Wetterö J; Sjöwall C
    J Clin Med; 2021 Dec; 10(24):. PubMed ID: 34945133
    [TBL] [Abstract][Full Text] [Related]  

  • 39. C-reactive protein and inflammation: conformational changes affect function.
    Wu Y; Potempa LA; El Kebir D; Filep JG
    Biol Chem; 2015 Nov; 396(11):1181-97. PubMed ID: 26040008
    [TBL] [Abstract][Full Text] [Related]  

  • 40. C-reactive protein, inflammation, and innate immunity.
    Mortensen RF
    Immunol Res; 2001; 24(2):163-76. PubMed ID: 11594454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.